CLINICAL_TRIALS
trial_result
· 2020-03-30
Clinical Trial Update: A Multicenter Assessment of ALD403 in Chronic Migraine [Phase 2]
Summary
Phase 2 multicenter trial assessing ALD403 for chronic migraine has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alder Biopharmaceuticals, Inc. | Conditions: Migraine Disorders | Phase 2 | Status: COMPLETED | Results posted: 2020-03-30